| Model No. | Nomenclature | Genotype |
|---|---|---|
| 13686-F | NOD.Cg-Prkdcscid Il2rgtm1Sug Tg(CMV-IL6)1-1Jic/JicTac | sp/sp;ko/ko;tg/wt |
| 13686-M | NOD.Cg-Prkdcscid Il2rgtm1Sug Tg(CMV-IL6)1-1Jic/JicTac | sp/sp;ko/y;tg/wt |
hIL-6 NOG
View:
Select One
- Description
- Data
- Price & Licensing
- Health Report
- Overview
- Genetics
- Guides & Publications
- Applications & Therapeutic Areas
- Transit, Housing & Welfare
- Diet
Overview
Nomenclature: NOD.Cg-Prkdcscid Il2rgtm1Sug Tg(CMV-IL6)1-1Jic/JicTac
- Super immunodeficient NOG mouse expressing human IL-6 cytokine
- Enhanced expansion of human monocytes following human HSC engraftment
- May be useful for study of tumor-infiltrating macrophages
- May be suitable host for hIL-6 dependent multiple myeloma (MM) patient derived xenograft (PDX) and tumor samples.
- Applications in research involving cancer, immunology, regenerative medicine and human immune system engraftment
What our customers say:
“Experimental Pharmacology & Oncology (EPO) GmbH uses 1st and 2nd generation NOG mice provided by Taconic for its preclinical oncology service. These mice are included in novel concepts for the development of personalized treatment options and especially suited for humanization strategies. We are very satisfied with the quality of mice, the reliability of shipment and the high level of scientific support. Further, we very much appreciate the competent and always friendly communication.”
Experimental Pharmacology & Oncology (EPO) GmbH
Availability
Available now**Please note that advanced order placement is encouraged for male mice. Ordering 4 or more weeks prior to the desired shipping date is recommended when requesting males older than 3-weeks of age.
Origin
Genetics
Guides & Publications
Initial Publication: Hanazawa A, Ito R, Katano I, Kawai K, Goto M, Suemizu H, Kawakami Y, Ito M, Takahashi T. (2018) Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice. Front Immunol 9:152.
Applications & Therapeutic Areas
- Immunology
- Inflammation
- Oncology & Immuno-Oncology
- Cell and Tissue Humanized
Transit, Housing & Welfare
Need more info? Click the live chat button or Contact Us
Packing Practices
Taconic standard practice is to recombine animals of different home cages and/or ages from a single model and sex during packing, except in specific cases where Taconic's animal welfare policy prohibits recombination due to aggression or other concerns. When an order is fulfilled with animals from more than one week of birth, this standard practice results in animals from a range of birth weeks packed together in a single TTC. When an order is fulfilled with animals from genotyped models, this standard practice results in animals from different home cages packed together in a single TTC.
Customers who wish to keep animals from different weeks of birth separated should place orders with the special instruction "Divide and label by age." Note that this special request can result in increased costs for additional Taconic Transit Cages, dividers and/or freight charges.
Taconic discourages other types of custom packing requests as they can have a negative impact on animal welfare. Learn more.
Diet
Data
Humanized hIL-6 NOG Mice Supports Human Monocytes/Macrophages & Immunosuppressive Human Tumor Microenvironment
Development of human monocytes/macrophages in hIL-6 NOG engrafted with human CD34+ stem cells
Figure 1: (a) The frequency of CD33+CD14+ monocytes/macrophages in hCD45+ leukocytes, obtained by flow cytometry. (b) The absolute number of CD33+CD14+ monocytes/macrophages, calculated by multiplying the number of total MNCs by the frequencies of each human subpopulation determined by FACS. (c) The distributions of human macrophages in HSC-engrafted NOG and hIL-6 NOG mice, assessed in paraffin-embedded lung, liver, spleen, and BM. Adapted from Hanazawa, et al. 2018 under Creative Commons Attribution License.
Development of human tumor-associated macrophages (TAMs) in tumor-engrafted humanized hIL-6 NOG mice
Figure 2: (a) Schema of generation of tumor-bearing humanized mice. (b) Immunohistochemistry of human macrophages in tumor and spleen at 36-51 days after tumor transplantation. (c) Enumeration of CD68+ or CD163+ macrophages. (d) Expression of IL-4Rα in human macrophages. FACS plots of IL-4Rα in hCD45+CD14+CD68+ macrophages in tumor, spleen, and PB of HSC4-engrafted HSC-NOG-hIL-6 Tg (upper panels) and histogram of hIL-4Rα expression in hCD68+ macrophages in various tissues (bottom panel). Adapted from Hanazawa, et al. 2018 under Creative Commons Attribution License.
- Licensing
- Pricing - USD
- Pricing - EUR
- Pricing - USD Nonprofit
- Pricing - EUR Nonprofit
- Select my Health Standard
- Get Custom Pricing Guide
hIL-6 NOG
Nonprofit users (excluding users at nonprofit foundations which are affiliated with a for-profit entity): For internal research purposes, the CIEA NOG mouse® Conditions of Use for nonprofit users apply. If you wish to perform sponsored research or fee-for-service contract research using the CIEA NOG mouse®, please inquire for access conditions.
For-profit users and users at foundations which are affiliated with for-profit entities: The CIEA NOG mouse® Conditions of Use for for-profit users apply.
The CIEA NOG mouse® is produced and distributed under license rights to the following patents and trademarks:
- Japanese Patent No. 3,753,321
- US Patent No. 7,145,055; 5,464,764; 5,487,992; 5,627,059; 5,631,153; 5,789,215; 6,204,061; 6,653,113; 6,689,610
EP Patent No. 1,338,198 - Japanese Trademark Reg. No. 4,823,423
- US Trademark Reg. No. 3,118,040
- EU Trademark Reg. No. 3,736,758
Pricing - USD
Opportunist Free (OF) Health Standard
13686 Female
13686-F Genotype sp/sp;ko/ko;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | $501.00 |
13686 Male
13686-M Genotype sp/sp;ko/y;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | $501.00 |
Pricing - EUR
Opportunist Free (OF) Health Standard
13686 Female
13686-F Genotype sp/sp;ko/ko;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | €441,00 |
13686 Male
13686-M Genotype sp/sp;ko/y;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | €441,00 |
Pricing - USD Nonprofit
Opportunist Free (OF) Health Standard
13686 Female
13686-F Genotype sp/sp;ko/ko;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | $321.00 |
13686 Male
13686-M Genotype sp/sp;ko/y;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | $321.00 |
Pricing - EUR Nonprofit
Opportunist Free (OF) Health Standard
13686 Female
13686-F Genotype sp/sp;ko/ko;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | €257,00 |
13686 Male
13686-M Genotype sp/sp;ko/y;tg/wt
| Age in Weeks | Quantity 1 - 999 |
| 3 to 10 | €257,00 |
Select my Health Standard
Need help choosing the right Taconic Biosciences health standard for your research?
Use the Health Standard Selector to enter your exclusion list. The tool will tell you which health standards meet your requirements.
Get custom pricing guide
Schedule A Scientific Consultation
Speak with a PhD-level Field Application Scientist who can help you select the most appropriate model and maximize your experimental success.
Related Models
Smart Select Program
Trial an Animal Model for Quality & Compatibility Assurance
As longtime facilitators of animal-based research, we understand the importance of aligning your project goals and procurement priorities to support advancements in your research.
- Evaluate a specific model strain, before making any financial investment
- Request up to 20 animals from one of the strains listed below, to test for quality, consistency, and suitability for your experimental purpose
- Enjoy free ground shipping, where applicable (see table for more details)*